Teva Receives US FDA Approval for Generic Version of Epipen Auto-Injector
Shots:
- Teva’s EpiPen and EpiPen Jr (epinephrine) auto-injector will be used to treat allergic reaction including anaphylaxis in adults and pediatric patients weighing >33 pounds
- The US FDA approval is prompted to lower cost along with safety and effectiveness for patients
- EpiPen will be marketed in 0.3 mg and 0.15 mg doses
/ | Ref: US FDA | Image: Seeking alpha
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com